Evidence map›Paper›PMID 42166015›Full record

ArticleEuropean radiology2026

What you see is not always what you get-MRI-based ganglionic eminence volumetry challenges subjective assessment in CNS anomalies.

Marlene Stuempflen, Patric Kienast, Victor U Schmidbauer, Michael Weber, Athena Taymourtash, Johannes Tischer, Tim Dorittke, Julia Binder, Daniela Prayer, Gregor Kasprian

Abstract read
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marlene StuempflenDepartment of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Patric KienastDepartment of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Victor U SchmidbauerDepartment of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Michael WeberDepartment of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Athena TaymourtashComputational Imaging Research Lab, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Johannes TischerComputational Imaging Research Lab, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Tim DorittkeDepartment of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, Vienna, Austria.
Julia BinderDepartment of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, Vienna, Austria.
Daniela PrayerDepartment of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Gregor KasprianDepartment of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria. gregor.kasprian@meduniwien.ac.at.ORCID http://orcid.org/0000-0003-3858-3347

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare prenatal imaging-based subjective assessment of the ganglionic eminence (GE) on fetal MRI with three-dimensional volumetric analysis in patients with structural central nervous system anomalies. MATERIALS AND

methodsThis retrospective study investigated 17 fetuses (undergoing 20 fetal MRIs, mean gestational age 26.3 weeks, SD 3.3, range 21.7-33.4 weeks) with enlarged GE based on subjective assessment of fetal neuroimaging experts and concurrent structural brain anomalies. Three-dimensional volumetry of super-resolution MRI was performed and compared to age-matched neurotypical controls (94 fetuses, 100 MRIs, mean age 27.2 weeks, SD 3.6, range 21.7-34.0 weeks).

resultsAmong 20 MR examinations, in only 5 cases (25%) GE hyperplasia was confirmed, while 12 (60%) were found to show normal GE volumes. In 3 (15%), GE volumes were smaller compared to controls. Most patients (80%) were found to have increased total brain volume, while only 30% had an increased intracranial volume-ventriculomegaly (75%) seemingly being the most common underlying cause. Brain parenchyma volume was enlarged in only 20%. No correlation was found between GE volumes and volumes of 10 other substructures of the fetal head in pathological cases.

conclusionThe study suggests the unreliability of expert visual assessment of GE size, despite excellent examination conditions, emphasizing the need for three-dimensional volumetric GE measurements. Specifically in patients with structural brain anomalies, quantitative fetal neuroimaging serves as an emerging tool to identify abnormalities in GE size and complement current diagnostic techniques by objectifying subjective impressions. KEY POINTS: Question To evaluate the reliability of expert visual assessment of ganglionic eminence size in fetal MRI compared to super-resolution brain volumetry. Findings Expert visual assessment and 2D fetal brain biometry were insufficient to provide correct volumetric quantification of the ganglionic eminence in the investigated patient collective. Clinical Relevance This study highlights the value of volumetric quantification of the ganglionic eminence in fetal MRI to provide an objective, reproducible and valid quantitative tool for assessment of the fetal brain, specifically in the presence of CNS anomalies.

Indexed as

Ganglionic EminenceImaging, Three-DimensionalMagnetic Resonance ImagingNervous System MalformationsPrenatal DiagnosisFemaleHumansPregnancyReproducibility of ResultsRetrospective StudiesSensitivity and SpecificityCNSFetal MRIFetal neurodevelopmentGanglionic eminenceMagnetic resonance imaging

Identifiers

PMID42166015
PMCPMC13574848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.